Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

CD61 Mouse anti-Human, Oligo, Clone: VI-PL2 (also known as VIPL2), BD™ AbSeq ™

Catalog No. BDB940065 Shop All BD Biosciences Products
Change view
Click to view available options
Quantity:
25 Tests
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
BDB940065 25 Tests
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
This item is not returnable. View return policy
Catalog No. BDB940065 Supplier BD Biosciences Supplier No. 940065
Add to Cart
Add to Cart
This item is not returnable. View return policy

Mouse Monoclonal Antibody

CD61 Monoclonal antibody specifically detects CD61 in Human samples. It is validated for Single Cell 3' Sequencing
TRUSTED_SUSTAINABILITY

Specifications

Antigen CD61
Applications Single Cell 3' Sequencing
Classification Monoclonal
Clone Clone VI-PL2 (also known as VIPL2)
Conjugate Oligo
Formulation Aqueous buffered solution containing BSA and ≤0.09% sodium azide.
Gene Alias Integrin β3; Integrin beta-3; GP3A; GPIIIa; ITGB3; ITB3
Host Species Mouse
Quantity 25 Tests
Regulatory Status RUO
Primary or Secondary Primary
Target Species Human
Content And Storage Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography and conjugated to BD AbSeq oligonucleotide under optimal conditions.
Isotype IgG1 κ
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.